Gestational Age at Birth and Clinical Manifestations of Spinal Muscular Atrophy
Early detection and timely administration of treatments are imperative in managing the rapid and severe loss of motor function that can occur in neonates with SMA. A personalized obstetric health care approach, prenatal testing, and planning the timing of delivery and initiation of treatment for newborns with genetically diagnosed SMA may improve outcomes.
Authors
- Karen Herbert
- Didu Kariyawasam (ORCID: https://orcid.org/0000-0002-4176-4010)
- Nancy Briggs (ORCID: https://orcid.org/0000-0002-1134-0807)
- Michelle A. Farrar (ORCID: https://orcid.org/0000-0002-4472-0902)
- Jacqui Russell
- Melissa R. Mandarakas (ORCID: https://orcid.org/0000-0002-6604-3973)
- Anita Cairns (ORCID: https://orcid.org/0000-0002-7123-0351)
- Tejaswi Kandula (ORCID: https://orcid.org/0000-0002-4355-4965)
- Hugo Sampaio
- Zena Junek
Institutions
- UNSW Sydney (AU)
- Sydney Children's Hospital (AU)
- Sydney Children’s Hospitals Network (AU)
- Children's Health Queensland Hospital and Health Service (AU)
Publication Details
- Journal
- Neurology
- Published
- 2025-06-27
- DOI
- https://doi.org/10.1212/wnl.0000000000213799
- Citations
- 6
- Primary Topic
- Neurogenetic and Muscular Disorders Research
- Type
- article
- Field-Weighted Citation Impact
- 9.75